It binds directly to the demethylase catalytic site of the KDM4 protein, reducing its activity in addition to suppressing the development of many cancer cells, while having minimal toxicity to and adverse effects on normal tissue cells [143,144]. The gene discussed is MBD2; the disease is cancer.